Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1014645-87-4

Post Buying Request

1014645-87-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1014645-87-4 Usage

General Description

Benzoic acid, 4-(1-aminocyclopropyl)-, methyl ester, hydrochloride (1:1) is a chemical compound that consists of benzoic acid, methyl ester, and hydrochloride in a 1:1 ratio. It is a white, crystalline powder that is commonly used in pharmaceutical and organic synthesis applications. Benzoic acid, 4-(1-aminocyclopropyl)-, methyl ester, hydrochloride (1:1) has potential pharmaceutical properties and has been studied for its potential use as an antifungal agent. It is also known to have antibacterial and antiviral properties. Additionally, this chemical may have potential applications in the treatment of various diseases and disorders. Overall, Benzoic acid, 4-(1-aminocyclopropyl)-, methyl ester, hydrochloride (1:1) is a versatile compound with potential uses in medicine and pharmaceuticals.

Check Digit Verification of cas no

The CAS Registry Mumber 1014645-87-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,4,6,4 and 5 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1014645-87:
(9*1)+(8*0)+(7*1)+(6*4)+(5*6)+(4*4)+(3*5)+(2*8)+(1*7)=124
124 % 10 = 4
So 1014645-87-4 is a valid CAS Registry Number.

1014645-87-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (JWP00449)  4-(1-Amino-cyclopropyl)-benzoic acid methyl ester hydrochloride  AldrichCPR

  • 1014645-87-4

  • JWP00449-1G

  • 5,151.51CNY

  • Detail

1014645-87-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Benzoic acid, 4-(1-aminocyclopropyl)-, methyl ester, hydrochloride (1:1)

1.2 Other means of identification

Product number -
Other names Methyl cumate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1014645-87-4 SDS

1014645-87-4Relevant articles and documents

NOVEL INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

-

Page/Page column 153, (2020/11/13)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

PHENOXYETHYL PIPERIDINE COMPOUNDS

-

Page/Page column 10, (2014/01/17)

The present invention provides a compound of the Formula II: Formula II wherein X is: R1 is H, -CN, or F; R2 is H or methyl; R3 is H; and R4 is H, methyl, or ethyl; or R3 and R4 joined toge

PYRIDINE AMIDE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS

-

Page/Page column 38-39, (2012/06/30)

The invention relates pyridine amide derivative of Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are independently hydrogen, linear o branched (C1-C3)alkyl or joined together they form a cyclopropyl ring; R is independently selected from the group consisting of halogens and trifluoromethyl and p is 1, 2 or 3; A is C or N; E is a group of formula (B) or (C), wherein B is C(O)OH, C(O)O(C1-C3)alkyl, and C is selected from the group consisting of formula (I) m is 1,2 or 3, n is 0 or 1, W is -O-, -O(C1-C3 alkyl)-; -(C1-C3 alkyl)O-; -C(O)-; -C(=N-O(C1-C3 alkyl))-; -NH- or -NH(C1-C3alkyl)-; Ar is phenyl, optionally substituted with one or more substituents selected from the group consisting of halogen, trifluoromethyl, trifluoromethoxy, methyl, -NH(C1-C3alkyl)-; -N(C1-C3alkyl)(C1-C3alkyl)-, a from 5 to 7 membered heterocyclic ring containing one nitrogen atom which is convalently bonded to Ar and optionally containing one or two heteroatoms selected from N, O and S; and a 5- or 6-membered heteroaromatic ring containing 1 to 3 heteroatoms selected from S, O e N, such heteroaromatic ring being substituted with one or two substituents selected from the group consisting of (C1-C3)alkyl, (C3-C5)cycloalkyloxy, (C1-C3)alkylcarbonyl. The compounds of the invention could be used for manufacturing a medicament for the treatment of pathologies which require the use of an antagonist of the EP4 receptor, such as the treatment of acute and chronic pain, inflammatory pain, osteoarthritis, inflammation-associated disorder as arthritis, rheumatoid artrhritis, cancer, endometriosis and migraine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1014645-87-4